Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$7,217,286
+$844,395 QoQ
Shares Held
28,681
-2.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#1,087
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $25,845,902 across 12 Drug Manufacturers - General names. ABBV ranks #1 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
28,681 | $7,217,286 | |
| 2 | NVS |
Novartis AG
|
26,136 | $4,096,033 | |
| 3 | JNJ |
Johnson & Johnson
|
13,995 | $3,554,310 | |
| 4 | NVO |
Novo Nordisk A S
|
70,160 | $3,363,470 | |
| 5 | MRK |
Merck & Co., Inc.
|
24,621 | $3,163,798 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,721 | $1,366,804 | |
| 7 | LLY |
ELI LILLY & Co
|
971 | $1,164,646 | |
| 8 | AZN |
Astrazeneca PLC
|
3,262 | $618,540 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,217,286 | 28,681 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $6,372,891 | 29,302 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $6,949,294 | 30,414 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $7,181,907 | 31,018 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,864,663 | 31,595 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $6,676,983 | 31,868 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $5,822,695 | 32,767 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $6,831,030 | 34,591 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,992,051 | 34,935 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,415,929 | 35,233 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,506,084 | 35,530 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $5,243,334 | 35,176 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,810,265 | 35,703 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,900,036 | 37,021 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $6,041,143 | 37,381 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,064,682 | 37,737 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,821,458 | 38,009 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $6,128,730 | 37,806 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,302,534 | 39,162 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,220,198 | 39,123 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,447,590 | 39,485 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,273,716 | 39,491 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,249,461 | 39,659 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,319,135 | 37,894 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,687,248 | 37,556 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,738,420 | 35,942 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||